These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32424818)
1. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway. Ma N; Zhao Y Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818 [TBL] [Abstract][Full Text] [Related]
2. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN. Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121 [TBL] [Abstract][Full Text] [Related]
3. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance. Liu T; Jin ZW; Li Y; Zhang G; Yang XY; Xu XM; Ma YC J Cancer Res Ther; 2022 Apr; 18(2):488-495. PubMed ID: 35645119 [TBL] [Abstract][Full Text] [Related]
4. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer. Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346 [TBL] [Abstract][Full Text] [Related]
5. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells. Miao F; Zhang X; Cao Y; Wang Y; Zhang X BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922 [TBL] [Abstract][Full Text] [Related]
6. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
7. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway. Zhu J; Hu H; Wang J; Yang Y; Yi P Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366 [TBL] [Abstract][Full Text] [Related]
8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
9. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway. Xiao H; Zheng Y; Chen J; Shen H Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826 [TBL] [Abstract][Full Text] [Related]
10. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells Yang H; Li H; Lu S; Shan S; Guo Y Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608 [TBL] [Abstract][Full Text] [Related]
11. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849 [TBL] [Abstract][Full Text] [Related]
12. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway. Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213 [TBL] [Abstract][Full Text] [Related]
13. [6]-Gingerol enhances the cisplatin sensitivity of gastric cancer cells through inhibition of proliferation and invasion via PI3K/AKT signaling pathway. Luo Y; Zha L; Luo L; Chen X; Zhang Q; Gao C; Zhuang X; Yuan S; Qiao T Phytother Res; 2019 May; 33(5):1353-1362. PubMed ID: 30811726 [TBL] [Abstract][Full Text] [Related]
14. Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway. Ma J; Liu L; Ling Y; Zheng J J Biochem Mol Toxicol; 2021 Sep; 35(9):e22853. PubMed ID: 34309113 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression. Karam AK; Santiskulvong C; Fekete M; Zabih S; Eng C; Dorigo O Cytoskeleton (Hoboken); 2010 Aug; 67(8):535-44. PubMed ID: 20607860 [TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway. Yang N; Qu YJ; Cheng Y; Liang T; Zhang MN; Zhang D; Dong LN; Wang XW; Zhang GM Cancer Biomark; 2017 Jul; 19(3):263-269. PubMed ID: 28453460 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway. Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway. Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells. Zhang X; Lin J; Ma Y; Zhao J Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]